Table 4 Preparations containing Mylabris or its related active ingredients
Preparations | Countries | Drug dosage forms | Composition | Indications | Specification | Usage | Maximum clinical efficiency | References |
|---|---|---|---|---|---|---|---|---|
Compound CTD capsule | China | Capsule | Mylabris, Panax ginseng, Astragali Radix, Acanthopanax senticosus, Sparganii Rhizoma, Scutellaria barbata, Curcuma zedoaria, Corni Fructus, Ligustri Lucidi Fructus, Bear bile powder, Licorice, etc | Primary liver cancer, lung cancer, rectal cancer, malignant lymphoma, gynecological malignant tumor | 0.25 g/capsule | Oral | 95.80% | |
Delisheng injection | China | Injection | Mylabris, Red ginseng, Astragali Radix, Bufonis Venenum | Middle and advanced primary liver cancer with Qi deficiency and blood stasis syndrome | 10 mL each | Intravenous drip | 93.75% | |
Ganning tablets | China | Tablet | Mylabris, Armillaria Pachyderma, Glutinous rice | Acute and chronic hepatitis, abnormal liver function, hepatitis B patients, prevention of hepatitis B cancer | Each tablet weighs 0.3 g | Oral | 95.45% | [39] |
SC and vitamin B6 injection | China | Injection | SC and Vitamin B6 | Liver cancer, lung cancer, leukopenia, hepatitis, cirrhosis, hepatitis B virus carriers | 0.05 mg/5 mL, 0.1 mg/10 mL | Intravenous drip | 92.00% | |
Mylabris mustard ointment | China | Cream | Mylabris, White mustard, Bone-seeking Wind | Tennis elbow management | Appropriate amount | Topical application | 100.00% | [101] |
Croton Mylabris ointment | China | Cream | Croton, Mylabris, Ginger | Peripheral facial paralysis | Appropriate amount | Topical application | 94.30% | [102] |
SC injection | China | Injection | SC | Primary liver cancer, esophageal cancer | 0.1 mg/2 mL, 0.25 mg/ mL, 0.5 mg/10 mL | Intravenous drip | 91.07% | |
CTD cream | China | Cream | CTD | Genital warts | 1 mg/4 g | Topical application | 90.00% | |
Ycanth (VP-102) | USA | Solution | CTD | Molluscum Contagiosum | 0.7% W/V | Topical application | 85.70% | [106] |